Rinvoq ER 15 MG tablet UU 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F1AZ8
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $104,046
Award facts
- Contract value 100% obligated
- $104,045.83 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $104,045.83 to AmerisourceBergen Drug Corp for RINVOQ ER 15 mg tablets (30-count units) on January 29, 2026, with completion targeted for January 30, 2026. This firm fixed-price, non-set-aside contract is executed at the awardee's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, a $999,999,999.00 vehicle running through December 31, 2031, which serves as the primary procurement mechanism for pharmaceutical products and medical supplies supporting military healthcare programs globally.
AmerisourceBergen operates as a critical pharmaceutical distributor for federal medical procurement, particularly for Defense Health Agency and military treatment facilities. The company's extensive contract portfolio with DLA demonstrates its capability to supply diverse pharmaceutical products across multiple therapeutic domains through competitively awarded arrangements. This delivery order for RINVOQ ER, an oral immunosuppressive medication used in rheumatoid arthritis treatment, reflects the company's role in supporting the military healthcare supply chain with specialty medications and essential pharmaceutical commodities required by federal medical institutions worldwide.
Quick answers
Who was awarded contract SPE2DR26F1AZ8?
SPE2DR26F1AZ8 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 29, 2026.
How much is contract SPE2DR26F1AZ8 worth?
The government has obligated $104,046 on SPE2DR26F1AZ8.
Is contract SPE2DR26F1AZ8 an order under another contract?
Yes. SPE2DR26F1AZ8 is a delivery order under SPE2DR25D1205, an indefinite delivery contract.
Was contract SPE2DR26F1AZ8 competed?
The extent of competition for SPE2DR26F1AZ8 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award